Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

North America Survey Reveals Better Customer Data Essential to Digital Transformation
North America Survey Reveals Better Customer Data Essential to Digital Transformation


Access to quality customer reference data is more important than ever as the life sciences industry shifts to digital engagement, according to new research from Veeva Systems (NYSE: VEEV). Findings

EUROIMMUN Launches Quantitative ELISA to Measure SARS-CoV-2 Antibodies Against Viral S1 Protein: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24701/263px-PerkinElmer.svg.png
EUROIMMUN Launches Quantitative ELISA to Measure SARS-CoV-2 Antibodies Against Viral S1 Protein


PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, announced today that EUROIMMUN, a PerkinElmer company, has launched the Anti-SARS-CoV-2 QuantiVacTM

 Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study
 Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study


Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in

Pfizer Announces Positive Phase 3 Study Results for XELJANZ ® (tofacitinib) in Ankylosing Spondylitis (AS)http://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Announces Positive Phase 3 Study Results for XELJANZ ® (tofacitinib) in Ankylosing Spondylitis (AS)


Pfizer Inc. (NYSE: PFE) announced today positive results from a Phase 3 investigational study evaluating the safety and efficacy of tofacitinib in adults with active ankylosing spondylitis (AS)

PerkinElmer to Present at Wolfe Virtual Healthcare Conference: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24701/263px-PerkinElmer.svg.png
PerkinElmer to Present at Wolfe Virtual Healthcare Conference


PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Wolfe Virtual Healthcare Conference on Thursday

Pfizer Announces Details for When-Issued and Ex-Distribution Trading of Viatris and Pfizer Common Stockhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Pfizer Announces Details for When-Issued and Ex-Distribution Trading of Viatris and Pfizer Common Stock


Pfizer Inc. (NYSE: PFE) announced today further details regarding the proposed spin-off of its Upjohn Business and the subsequent combination of Mylan and the Upjohn Business to form Viatris Inc

Axsome Therapeutics und Veeva Systems kooperieren beim Aufbau der digital-zentrierten Commercialization™-Plattform von Axsome
Axsome Therapeutics und Veeva Systems kooperieren beim Aufbau der digital-zentrierten Commercialization™-Plattform von Axsome


Axsome Therapeutics, Inc. (NASDAQ: AXSM), ein biopharmazeutisches Unternehmen, das neuartige Therapien für die Behandlung von Erkrankungen des Zentralnervensystems (ZNS) entwickelt, und Veeva

Agilent Collaborates With SGS to Release New US EPA Method for the Analysis of Dioxins Using GC/TQ
Agilent Collaborates With SGS to Release New US EPA Method for the Analysis of Dioxins Using GC/TQ


Agilent Technologies Inc. (NYSE: A) announced today a collaboration with SGS has resulted in a new GC/TQ method, the SGS AXYS Method 16130, approved by the US EPA as an alternative method for the

PerkinElmer to Present at Stifel Virtual Healthcare Conference: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24701/263px-PerkinElmer.svg.png
PerkinElmer to Present at Stifel Virtual Healthcare Conference


PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Stifel Virtual Healthcare Conference on Tuesday

Axsome Therapeutics and Veeva Systems Partner to Build Axsome’s Digital-Centric Commercialization™ Platform
Axsome Therapeutics and Veeva Systems Partner to Build Axsome’s Digital-Centric Commercialization™ Platform


Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, and Veeva Systems (NYSE: VEEV), today

Axsome Therapeutics and Veeva Systems Partner to Build Axsome’s Digital-Centric Commercialization™ Platform
Axsome Therapeutics and Veeva Systems Partner to Build Axsome’s Digital-Centric Commercialization™ Platform


Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, and Veeva Systems (NYSE: VEEV), today

Bristol Myers Squibb and MyoKardia Announce Expiration of HSR Act Waiting Period
Bristol Myers Squibb and MyoKardia Announce Expiration of HSR Act Waiting Period


Bristol Myers Squibb (NYSE: BMY) and MyoKardia, Inc. (Nasdaq: MYOK) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, or HSR Act

Quidel to Host Virtual Investor Day on November 12, 2020
Quidel to Host Virtual Investor Day on November 12, 2020


Quidel Corporation (NASDAQ:QDEL), provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will host its Quidel

Digitale Führungskräfte von Almirall und Merck KGaA, Darmstadt, Deutschland als Hauptredner auf dem Veeva-Online-Gipfel in Europa
Digitale Führungskräfte von Almirall und Merck KGaA, Darmstadt, Deutschland als Hauptredner auf dem Veeva-Online-Gipfel in Europa


Veeva Systems (NYSE: VEEV) gab heute bekannt, dass Dr. Francesca Domenech Wuttke, Chief Digital Officer bei Almirall, und Alessandro de Luca, CIO des Gesundheitswesens bei Merck KGaA, Darmstadt

Dexcom to Host Investor Day on December 9, 2020: https://mms.businesswire.com/media/20191106005764/en/685171/5/Dexcom_Registered_no_bug.jpg
Dexcom to Host Investor Day on December 9, 2020


DexCom, Inc. (NASDAQ:DXCM) announced today that it will host an Investor Day on December 9, from 8:30 AM until approximately 11:30 AM Pacific Standard Time (11:30 AM – 2:30 PM Eastern). The event

Digital Leaders from Almirall and Merck KGaA, Darmstadt, Germany to Keynote Veeva Summit Online, Europe
Digital Leaders from Almirall and Merck KGaA, Darmstadt, Germany to Keynote Veeva Summit Online, Europe


Veeva Systems (NYSE: VEEV) today announced that Dr. Francesca Domenech Wuttke, chief digital officer at Almirall, and Alessandro de Luca, CIO of healthcare at Merck KGaA, Darmstadt, Germany are

Waters Gives More Laboratories Access to Mass Spectrometry with Rapid, Easy, and Compact RADIAN ASAP System
Waters Gives More Laboratories Access to Mass Spectrometry with Rapid, Easy, and Compact RADIAN ASAP System


Waters Corporation (NYSE:WAT) today introduced the new RADIAN™ ASAP™ System, a novel direct mass detector engineered for non-mass spectrometry (MS) experts to conduct fast and accurate analyses of

Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohnhttp://www.flickr.com/photos/w0ahitslo/6955091156/sizes/z/in/photostream/: All rights reserved by Queen Beuaroo
Mylan and Pfizer Receive Clearance from the U.S. Federal Trade Commission for Proposed Combination of Mylan and Upjohn


Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Federal Trade Commission (the “FTC”) accepted a proposed consent order, which concludes the FTC’s review of the

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2020
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2020


Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the third quarter of fiscal year 2020.



Third quarter 2020 results reflect strong sequential growth:




  • Revenue of $794

PerkinElmer COVID-19 Test Kit Receives FDA Emergency Use Authorization for Sample Pooling: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24701/263px-PerkinElmer.svg.png
PerkinElmer COVID-19 Test Kit Receives FDA Emergency Use Authorization for Sample Pooling


PerkinElmer, Inc. (NYSE: PKI) announced today that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) to allow sample pooling with PerkinElmer® New Coronavirus

Quidel Reports Third Quarter 2020 Financial Results
Quidel Reports Third Quarter 2020 Financial Results


Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the third

Agilent to Webcast Fourth-Quarter Fiscal Year 2020 Financial Results Presentation, Sets Date for Virtual Analyst and Investor Meeting
Agilent to Webcast Fourth-Quarter Fiscal Year 2020 Financial Results Presentation, Sets Date for Virtual Analyst and Investor Meeting


Agilent Technologies Inc. (NYSE: A) will release fourth-quarter fiscal year 2020 financial results after the stock market closes on Monday, Nov. 23. The company will host a live webcast of its

Bavarian Nordic führt Veeva CRM und Veeva Vault PromoMats zur digitalen Markteinführung neuer Impfstoffe ein
Bavarian Nordic führt Veeva CRM und Veeva Vault PromoMats zur digitalen Markteinführung neuer Impfstoffe ein


Veeva Systems (NYSE: VEEV) gab heute bekannt, dass Bavarian Nordic die Multichannel-Lösungen Veeva CRM und Veeva Vault PromoMats für die digitale Markteinführung neuer Produkte in den USA und

PerkinElmer Announces Financial Results for the Third Quarter of 2020: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24701/263px-PerkinElmer.svg.png
PerkinElmer Announces Financial Results for the Third Quarter of 2020


PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today reported financial results for the third quarter ended October 4, 2020.



The Company reported

Southwestern Health Resources and Humana Announce Value-Based Agreement in North Texas: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24514/Humana_logo.png
Southwestern Health Resources and Humana Announce Value-Based Agreement in North Texas


Southwestern Health Resources (SWHR) – the clinically integrated network for University of Texas Southwestern Medical Center (UT Southwestern), Texas Health Resources, and more than 5,000